As was already mentioned, its the days after the initial reaction that count, obviously a different outcome. In any event I am looking forward to the meeting on Monday with great anticipation. I expect to see clarification regarding the MTD for113. I would not be surprised if we hear about a new molecule. If we get a drop in the share price it will be only temporary. The second quarter of 2013 should be much better then the first quarter. The analyst who was dismissive of 113 truly appeared to have his own agenda in not explaining the true potential which 113 may have for the ALK and EGFR population. Have a good weekend.
News 
Market Data 
Discover 
